These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 20127517)
21. GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma. Zhang S; Zhang K; Ji P; Zheng X; Jin J; Feng M; Liu P BMC Cancer; 2017 May; 17(1):380. PubMed ID: 28549418 [TBL] [Abstract][Full Text] [Related]
22. HIF-2-dependent expression of stem cell factor promotes metastasis in hepatocellular carcinoma. Wang X; Dong J; Jia L; Zhao T; Lang M; Li Z; Lan C; Li X; Hao J; Wang H; Qin T; Huang C; Yang S; Yu M; Ren H Cancer Lett; 2017 May; 393():113-124. PubMed ID: 28153790 [TBL] [Abstract][Full Text] [Related]
23. (125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma. Hu PH; Pan LH; Wong PT; Chen WH; Yang YQ; Wang H; Xiang JJ; Xu M World J Gastroenterol; 2016 Jun; 22(21):5033-41. PubMed ID: 27275095 [TBL] [Abstract][Full Text] [Related]
24. Preparation of a monoclonal antibody against the carcinoembryonic antigen, glypican‑3. Zhang Y; Qiu D; Li R; Liu Y; Shi S; Wang Y Mol Med Rep; 2019 May; 19(5):3889-3895. PubMed ID: 30896845 [TBL] [Abstract][Full Text] [Related]
25. [Prepared the monoclonal antibody associated with hepatocellular carcinoma and analyzed its epitope]. Yang BF; Liu R; Liu Y; Yang JJ; Liu XL; Gao JE; Sun QH Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):780-3. PubMed ID: 21722534 [TBL] [Abstract][Full Text] [Related]
26. Latexin exhibits tumor suppressor potential in hepatocellular carcinoma. Ni QF; Tian Y; Kong LL; Lu YT; Ding WZ; Kong LB Oncol Rep; 2014 Mar; 31(3):1364-72. PubMed ID: 24399246 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma. Sun X; Jin Z; Song X; Wang J; Li Y; Qian X; zhang Y; Yin Y BMC Cancer; 2015 Dec; 15():961. PubMed ID: 26674738 [TBL] [Abstract][Full Text] [Related]
28. The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome. Yang SL; Liu LP; Jiang JX; Xiong ZF; He QJ; Wu C Jpn J Clin Oncol; 2014 Feb; 44(2):159-67. PubMed ID: 24374892 [TBL] [Abstract][Full Text] [Related]
29. Expression of a glypican-related 62-kDa antigen is decreased in hepatocellular carcinoma in correspondence to the grade of tumor differentiation. Lage H; Kellner U; Tannapfel A; Dietel M Virchows Arch; 2001 Jun; 438(6):567-73. PubMed ID: 11469688 [TBL] [Abstract][Full Text] [Related]
30. Prognostic significance and clinicopathological features of hypoxic inducible factor-2alpha expression in hepatocellular carcinoma. Yao Q; Lv Y; Pan T; Liu Y; Ma J; Xu G Saudi Med J; 2015 Feb; 36(2):170-5. PubMed ID: 25719580 [TBL] [Abstract][Full Text] [Related]
31. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2. Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350 [TBL] [Abstract][Full Text] [Related]
32. [In-vivo targeted imaging of hepatocellular carcinoma in nude mice using quantum dot probes]. Chen LD; Liu J; Yu XF; Pang DW; Wang QQ; Yuan HY; Tang ZY; Li Y Zhonghua Bing Li Xue Za Zhi; 2007 Jun; 36(6):394-9. PubMed ID: 17822625 [TBL] [Abstract][Full Text] [Related]
33. FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo. Fang F; Yang L; Tao Y; Qin W Cancer; 2012 Jan; 118(1):134-46. PubMed ID: 21713761 [TBL] [Abstract][Full Text] [Related]
34. Silencing of signal transducer and activator of transcription 3 expression by RNA interference suppresses growth of human hepatocellular carcinoma in tumor-bearing nude mice. Li J; Piao YF; Jiang Z; Chen L; Sun HB World J Gastroenterol; 2009 Jun; 15(21):2602-8. PubMed ID: 19496189 [TBL] [Abstract][Full Text] [Related]
35. [Expressions of phosphorylated-Smad2 and PTEN in hepatocellular carcinomas and adjacent liver tissues]. Wu SK; Wang BJ; Yang Y; Tian YJ; Bao JJ; Feng XH; Yang DL Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):567-71. PubMed ID: 17711623 [TBL] [Abstract][Full Text] [Related]
36. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma. Inoue M; Takahashi Y; Fujii T; Kitagawa M; Fukusato T World J Gastroenterol; 2014 Dec; 20(46):17541-51. PubMed ID: 25516669 [TBL] [Abstract][Full Text] [Related]
37. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation. Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501 [TBL] [Abstract][Full Text] [Related]
38. Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization. Yang LJ; Wang WL World J Gastroenterol; 2002 Oct; 8(5):808-14. PubMed ID: 12378620 [TBL] [Abstract][Full Text] [Related]
39. Plexin C1 Marks Liver Cancer Cells with Epithelial Phenotype and Is Overexpressed in Hepatocellular Carcinoma. Odabas G; Cetin M; Turhal S; Baloglu H; Sayan AE; Yagci T Can J Gastroenterol Hepatol; 2018; 2018():4040787. PubMed ID: 30327758 [TBL] [Abstract][Full Text] [Related]
40. LAMA4, highly expressed in human hepatocellular carcinoma from Chinese patients, is a novel marker of tumor invasion and metastasis. Huang X; Ji G; Wu Y; Wan B; Yu L J Cancer Res Clin Oncol; 2008 Jun; 134(6):705-14. PubMed ID: 18084776 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]